Corrigendum to ‘A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients’. [Redox Biology 45 (2021) 102037] (Redox Biology (2021) 45, (S2213231721001968), (10.1016/j.redox.2021.102037))

Cláudia M. Deus; Susana P. Pereira; Teresa Cunha-Oliveira; José Teixeira; Rui F. Simões; Fernando Cagide; Sofia Benfeito; Fernanda Borges; Nuno Raimundo; Paulo J. Oliveira

doi:10.1016/j.redox.2021.102117

Corrigendum to ‘A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients’. [Redox Biology 45 (2021) 102037] (Redox Biology (2021) 45, (S2213231721001968), (10.1016/j.redox.2021.102037))

Cláudia M. Deus
, Susana P. Pereira
, Teresa Cunha-Oliveira
, José Teixeira
, Rui F. Simões
, Fernando Cagide
, Sofia Benfeito
, Fernanda Borges
, Nuno Raimundo
, Paulo J. Oliveira

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

2.3. Cell culture conditions Skin fibroblasts from five sporadic late-onset PD (sPD) male patients and five age- and sex-matched healthy controls were obtained from a cell line repository of the Coriell Institute for Medical Research, USA (www.coriell.org), and their detailed information was previously described [43]. The repository ID numbers of control fibroblasts used were: ND29178, ND29179, ND34770, ND35044, and ND38530; the repository ID numbers of sPD fibroblasts used were: ND34265, ND35320, ND35322, ND35976, and ND39999.

Original language	English (US)
Article number	102117
Journal	Redox Biology
Volume	47
DOIs	https://doi.org/10.1016/j.redox.2021.102117
State	Published - Nov 2021

All Science Journal Classification (ASJC) codes

Organic Chemistry

Access to Document

10.1016/j.redox.2021.102117

Fingerprint

Dive into the research topics of 'Corrigendum to ‘A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients’. [Redox Biology 45 (2021) 102037] (Redox Biology (2021) 45, (S2213231721001968), (10.1016/j.redox.2021.102037))'. Together they form a unique fingerprint.

Cite this

Deus, C. M., Pereira, S. P., Cunha-Oliveira, T., Teixeira, J., Simões, R. F., Cagide, F., Benfeito, S., Borges, F., Raimundo, N., & Oliveira, P. J. (2021). Corrigendum to ‘A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients’. [Redox Biology 45 (2021) 102037] (Redox Biology (2021) 45, (S2213231721001968), (10.1016/j.redox.2021.102037)). Redox Biology, 47, Article 102117. https://doi.org/10.1016/j.redox.2021.102117

Deus, Cláudia M. ; Pereira, Susana P. ; Cunha-Oliveira, Teresa et al. / Corrigendum to ‘A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients’. [Redox Biology 45 (2021) 102037] (Redox Biology (2021) 45, (S2213231721001968), (10.1016/j.redox.2021.102037)). In: Redox Biology. 2021 ; Vol. 47.

@article{6f2ee0ffff4a46a8a7e28dbe86ed5df9,

title = "Corrigendum to {\textquoteleft}A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients{\textquoteright}. [Redox Biology 45 (2021) 102037] (Redox Biology (2021) 45, (S2213231721001968), (10.1016/j.redox.2021.102037))",

abstract = "2.3. Cell culture conditions Skin fibroblasts from five sporadic late-onset PD (sPD) male patients and five age- and sex-matched healthy controls were obtained from a cell line repository of the Coriell Institute for Medical Research, USA (www.coriell.org), and their detailed information was previously described [43]. The repository ID numbers of control fibroblasts used were: ND29178, ND29179, ND34770, ND35044, and ND38530; the repository ID numbers of sPD fibroblasts used were: ND34265, ND35320, ND35322, ND35976, and ND39999.",

author = "Deus, \{Cl{\'a}udia M.\} and Pereira, \{Susana P.\} and Teresa Cunha-Oliveira and Jos{\'e} Teixeira and Sim{\~o}es, \{Rui F.\} and Fernando Cagide and Sofia Benfeito and Fernanda Borges and Nuno Raimundo and Oliveira, \{Paulo J.\}",

note = "Publisher Copyright: {\textcopyright} 2021 The Author(s)",

year = "2021",

month = nov,

doi = "10.1016/j.redox.2021.102117",

language = "English (US)",

volume = "47",

journal = "Redox Biology",

issn = "2213-2317",

publisher = "Elsevier B.V.",

}

Deus, CM, Pereira, SP, Cunha-Oliveira, T, Teixeira, J, Simões, RF, Cagide, F, Benfeito, S, Borges, F, Raimundo, N & Oliveira, PJ 2021, 'Corrigendum to ‘A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients’. [Redox Biology 45 (2021) 102037] (Redox Biology (2021) 45, (S2213231721001968), (10.1016/j.redox.2021.102037))', Redox Biology, vol. 47, 102117. https://doi.org/10.1016/j.redox.2021.102117

Corrigendum to ‘A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients’. [Redox Biology 45 (2021) 102037] (Redox Biology (2021) 45, (S2213231721001968), (10.1016/j.redox.2021.102037)). / Deus, Cláudia M.; Pereira, Susana P.; Cunha-Oliveira, Teresa et al.
In: Redox Biology, Vol. 47, 102117, 11.2021.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Corrigendum to ‘A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients’. [Redox Biology 45 (2021) 102037] (Redox Biology (2021) 45, (S2213231721001968), (10.1016/j.redox.2021.102037))

AU - Deus, Cláudia M.

AU - Pereira, Susana P.

AU - Cunha-Oliveira, Teresa

AU - Teixeira, José

AU - Simões, Rui F.

AU - Cagide, Fernando

AU - Benfeito, Sofia

AU - Borges, Fernanda

AU - Raimundo, Nuno

AU - Oliveira, Paulo J.

PY - 2021/11

Y1 - 2021/11

N2 - 2.3. Cell culture conditions Skin fibroblasts from five sporadic late-onset PD (sPD) male patients and five age- and sex-matched healthy controls were obtained from a cell line repository of the Coriell Institute for Medical Research, USA (www.coriell.org), and their detailed information was previously described [43]. The repository ID numbers of control fibroblasts used were: ND29178, ND29179, ND34770, ND35044, and ND38530; the repository ID numbers of sPD fibroblasts used were: ND34265, ND35320, ND35322, ND35976, and ND39999.

AB - 2.3. Cell culture conditions Skin fibroblasts from five sporadic late-onset PD (sPD) male patients and five age- and sex-matched healthy controls were obtained from a cell line repository of the Coriell Institute for Medical Research, USA (www.coriell.org), and their detailed information was previously described [43]. The repository ID numbers of control fibroblasts used were: ND29178, ND29179, ND34770, ND35044, and ND38530; the repository ID numbers of sPD fibroblasts used were: ND34265, ND35320, ND35322, ND35976, and ND39999.

UR - https://www.scopus.com/pages/publications/85113538562

UR - https://www.scopus.com/pages/publications/85113538562#tab=citedBy

U2 - 10.1016/j.redox.2021.102117

DO - 10.1016/j.redox.2021.102117

M3 - Comment/debate

C2 - 34454869

AN - SCOPUS:85113538562

SN - 2213-2317

VL - 47

JO - Redox Biology

JF - Redox Biology

M1 - 102117

ER -

Deus CM, Pereira SP, Cunha-Oliveira T, Teixeira J, Simões RF, Cagide F et al. Corrigendum to ‘A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients’. [Redox Biology 45 (2021) 102037] (Redox Biology (2021) 45, (S2213231721001968), (10.1016/j.redox.2021.102037)). Redox Biology. 2021 Nov;47:102117. doi: 10.1016/j.redox.2021.102117

Corrigendum to ‘A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients’. [Redox Biology 45 (2021) 102037] (Redox Biology (2021) 45, (S2213231721001968), (10.1016/j.redox.2021.102037))

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this